Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ponce, PR
NPI
1932275484
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
Ponce by Pass Suite 809, Puma Medical Institute
Ponce, PR, 00717
Phone (787) 284-5299
Medicare paid, 2024
$14K
224 services
Medicare patients, 2024
70
Average age 73
Drug cost, 2024
$6.5M
23,612 prescriptions
Company payments, 2025
$175K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose M Garcia Mateo was code 99213 (office e&m - established), 142 times for 62 patients. In total Jose M Garcia Mateo billed 224 services in 10 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 142 | 62 | $56.62 | $8,041 |
| 99214 Office E&M - Established | Office | 34 | 25 | $80.87 | $2,750 |
By year: 2022 $11K for 208 services; 2023 $14K for 223 services; 2024 $14K for 224 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose M Garcia Mateo prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,374 prescriptions and refills. In total Jose M Garcia Mateo wrote 23,612 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,374 | 3,062 | 407 | $145K |
| Atorvastatin Calcium Generic | 1,843 | 2,628 | 408 | $16K |
| Rosuvastatin Calcium Generic | 1,459 | 2,031 | 309 | $15K |
| Metformin Hcl Generic | 1,287 | 1,789 | 265 | $8,007 |
| Trulicity Dulaglutide | 1,160 | 1,179 | 153 | $1.2M |
| Ezetimibe Generic | 875 | 1,135 | 176 | $11K |
| Farxiga Dapagliflozin Propanediol | 869 | 971 | 143 | $568K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 693 | 853 | 131 | $71K |
| Alendronate Sodium Generic | 685 | 908 | 146 | $4,664 |
| Jardiance Empagliflozin | 672 | 770 | 126 | $470K |
| Irbesartan Generic | 664 | 957 | 161 | $13K |
| Pioglitazone Hcl Generic | 651 | 939 | 129 | $9,435 |
| Ozempic Semaglutide | 557 | 575 | 84 | $552K |
| Amlodipine Besylate Generic | 478 | 651 | 108 | $2,278 |
| Olmesartan Medoxomil Generic | 452 | 592 | 106 | $6,038 |
Brand drugs: 10,134 claims; generic drugs: 13,319 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose M Garcia Mateo $175K ($175K in general payments such as food, travel and fees) from 21 companies. The largest payer was Lilly USA, LLC with $62K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 75 | $62K |
| Madrigal Pharmaceuticals MDGL | 56 | $37K |
| Corcept Therapeutics CORT | 37 | $27K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 24 | $23K |
| Amgen Inc. AMGN | 34 | $15K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $8,603 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $333 |
| Medtronic, Inc. MDT | 2 | $328 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $278 |
| Novo Nordisk Inc NVO | 11 | $212 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.